Gross and microscopic lesions in the female SENCAR mouse skin and lung in tumor initiation and promotion studies - PubMed (original) (raw)
- PMID: 3780637
- PMCID: PMC1474265
- DOI: 10.1289/ehp.866891
Gross and microscopic lesions in the female SENCAR mouse skin and lung in tumor initiation and promotion studies
G L Knutsen et al. Environ Health Perspect. 1986 Sep.
Abstract
The skin and lung tissues from SENCAR mice used as part of the Environmental Protection Agency's (EPA's) Carcinogenesis Testing Matrix were examined. This study included SENCAR mice used in three different short-term bioassay protocols in which the skin papilloma assay was used to identify initiators, promoters, and complete carcinogens. Also included were the pathology findings from SENCAR mice used in the combined bioassay in which the skin assay and the lung adenoma assay were conducted simultaneously. The gross and microscopic features of treatment-associated and spontaneous lesions of the skin and lung of the SENCAR mouse used in these studies are defined and the lesions most commonly observed are described. Generally, gross observations and microscopic findings in both the skin and lung tissues were poorly correlated. Although there are several definite criteria on which gross interpretations of the various skin and lung lesions can be made, with the exception of pedunculated squamous cell papillomas and the classic squamous cell carcinomas, the various lesion types had a wide variety of clinical presentations that severely compromised the accuracy of gross diagnosis. Further, in the case of benign skin neoplasms, malignant transformation of these tumors most often occurred at the base of the lesion and was initially hidden from gross observation. As a result, approximately 50% of the neoplasms interpreted clinically as benign tumors (papillomas and keratoacanthomas) were actually malignant neoplasms. Moreover, many lesions determined grossly to be nontumorous were in fact found to be neoplastic when examined microscopically. The SENCAR mouse was found to be more responsive in the lung adenoma assay than other strains examined with exception of the Strain A. Although accurate interpretation of the lung lesions in the SENCAR was compromised by nonneoplastic treatment-associated and/or spontaneous lesions, the feasibility of using the SENCAR skin and lung as target tissues in two-stage combined carcinogenesis studies merits further consideration.
Similar articles
- A combined carcinogen bioassay utilizing both the lung adenoma and skin papilloma protocols.
Robinson M, Bull RJ, Knutsen GL, Shields RP, Stober J. Robinson M, et al. Environ Health Perspect. 1986 Sep;68:141-5. doi: 10.1289/ehp.8668141. Environ Health Perspect. 1986. PMID: 3780626 Free PMC article. - NTP Comparative Initiation/Promotion Skin Paint Studies of B6C3F1 Mice, Swiss (CD-1(R)) Mice, and SENCAR Mice.
National Toxicology Program. National Toxicology Program. Natl Toxicol Program Tech Rep Ser. 1996 Feb;441:1-201. Natl Toxicol Program Tech Rep Ser. 1996. PMID: 12595922 - Malignant conversion and metastasis of mouse skin tumors: a comparison of SENCAR and CD-1 mice.
Hennings H, Spangler EF, Shores R, Mitchell P, Devor D, Shamsuddin AK, Elgjo KM, Yuspa SH. Hennings H, et al. Environ Health Perspect. 1986 Sep;68:69-74. doi: 10.1289/ehp.866869. Environ Health Perspect. 1986. PMID: 3780634 Free PMC article. - SENCAR mouse skin tumorigenesis model versus other strains and stocks of mice.
Slaga TJ. Slaga TJ. Environ Health Perspect. 1986 Sep;68:27-32. doi: 10.1289/ehp.866827. Environ Health Perspect. 1986. PMID: 3096709 Free PMC article. Review. - Genetic susceptibility to tumor progression in mouse skin carcinogenesis.
Stern MC, Conti CJ. Stern MC, et al. Prog Clin Biol Res. 1996;395:47-55. Prog Clin Biol Res. 1996. PMID: 8895983 Review. No abstract available.
Cited by
- Targeted deletion of Rad9 in mouse skin keratinocytes enhances genotoxin-induced tumor development.
Hu Z, Liu Y, Zhang C, Zhao Y, He W, Han L, Yang L, Hopkins KM, Yang X, Lieberman HB, Hang H. Hu Z, et al. Cancer Res. 2008 Jul 15;68(14):5552-61. doi: 10.1158/0008-5472.CAN-07-5670. Cancer Res. 2008. PMID: 18632607 Free PMC article. - PPARβ/δ promotes HRAS-induced senescence and tumor suppression by potentiating p-ERK and repressing p-AKT signaling.
Zhu B, Ferry CH, Blazanin N, Bility MT, Khozoie C, Kang BH, Glick AB, Gonzalez FJ, Peters JM. Zhu B, et al. Oncogene. 2014 Nov 13;33(46):5348-59. doi: 10.1038/onc.2013.477. Epub 2013 Nov 11. Oncogene. 2014. PMID: 24213576 Free PMC article. - Tumor promoter-induced sulfiredoxin is required for mouse skin tumorigenesis.
Wu L, Jiang H, Chawsheen HA, Mishra M, Young MR, Gerard M, Toledano MB, Colburn NH, Wei Q. Wu L, et al. Carcinogenesis. 2014 May;35(5):1177-84. doi: 10.1093/carcin/bgu035. Epub 2014 Feb 6. Carcinogenesis. 2014. PMID: 24503444 Free PMC article. - Naturally occurring nonneoplastic histopathological lesions in the female SENCAR mouse.
Kovatch RM, Knutsen GL, Robinson M. Kovatch RM, et al. Environ Health Perspect. 1986 Sep;68:105-15. doi: 10.1289/ehp.8668105. Environ Health Perspect. 1986. PMID: 3780622 Free PMC article. - Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) inhibits chemically induced skin tumorigenesis.
Bility MT, Devlin-Durante MK, Blazanin N, Glick AB, Ward JM, Kang BH, Kennett MJ, Gonzalez FJ, Peters JM. Bility MT, et al. Carcinogenesis. 2008 Dec;29(12):2406-14. doi: 10.1093/carcin/bgn219. Epub 2008 Sep 17. Carcinogenesis. 2008. PMID: 18799709 Free PMC article.
References
- Prog Exp Tumor Res. 1969;11:31-68 - PubMed
- CRC Crit Rev Toxicol. 1974 Jan;2(4):419-43 - PubMed
- Am J Pathol. 1981 May;103(2):174-80 - PubMed
- Gan. 1964 Jun;55:205-10 - PubMed
- Arch Dermatol. 1965 Jan;91:24-37 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials